BRIEF-Xvivo Perfusion Q2 net sales SEK 18.5 million

Wed Aug 13, 2014 2:39am EDT

Related Topics

Aug 13 (Reuters) - Xvivo Perfusion AB : * Q2 net sales SEK 18.5 million versus SEK 15.8 million * Q2 EBITDA SEK 1.8 million versus SEK 2.4 million * Source text for Eikon * Further company coverage

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.